Thirty-six-month outcome of prenatal cocaine exposure for term or near-term infants: Impact of early case management

Journal of Developmental and Behavioral Pediatrics

Volumn 21, Issue 1, 2000, Pages 19-26

  Kilbride, Howard ^a,c   Castor, Cheri ^a   Hoffman, Edward ^a   Fuger, Kathryn L ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Case management; Infant outcome; Prenatal cocaine

Indexed keywords

ADULT; AGE; ARTICLE; CASE MANAGEMENT; COCAINE DEPENDENCE; COMPARATIVE STUDY; DEVELOPMENTAL DISORDER; EVOKED AUDITORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MATERNAL BEHAVIOR; NEUROLOGIC EXAMINATION; NEWBORN; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRENATAL EXPOSURE; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; CASE MANAGEMENT; COCAINE-RELATED DISORDERS; DEVELOPMENTAL DISABILITIES; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MATERNAL BEHAVIOR; NEUROLOGIC EXAMINATION; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SEVERITY OF ILLNESS INDEX;

EID: 0034133508     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004703-200002000-00004     Document Type: Article

References (40)

1. Ostrea EM Jr, Brady M, Gause S, Raymundo AL, Stevens M: Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 89:107-113, 1992
2. Matera C, Warren WB, Moomjy M, Fink DJ, Fox HE: Prevalence of use of cocaine and other substances in an abusive population. Am J Obstet Gyneol 163:797-801, 1990
3. Ostrea EM Jr, Matias O, Keane C, et al: Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis. J Pediatr 133:913-915, 1998
4. Burkett G, Yasin SY, Palow D, La Voie L, Martinez M: Patterns of cocaine binging: Effect on pregnancy. Am J Obstet Gynecol 171:372-379, 1994
5. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA: Temporal patterns of cocaine use in pregnancy: Perinatal outcome. JAMA 261:1741-1744, 1989
6. Hoyme HE, Jones KL, Dixon SD, et al: Prenatal cocaine exposure and fetal vascular description. Pediatrics 95:743-747, 1990
7. King TA, Perlman JM, Laptook AR, Rollins N, Jackson G, Little B: Neurologic manifestations of in utero cocaine exposure in near-term and term infants. Pediatrics 96:259-264, 1995
8. Chiriboga CA, Vibbert M, Malouf R. et al: Neurological correlates of fetal cocaine exposure: Transient hypertonia of infancy and early childhood. Pediatrics 96:1070-1077, 1995
9. Mayes LC, Granger RH, Frank MA, Schottenfeld R, Bornstein MH: Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics 91:778-783, 1993
10. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K: Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics 101:237-241, 1998
11. Maone TR, Mattes RD, Beauchamp GK: Cocaine-exposed newborns show an exaggerated sucking response to sucrose. Physiol Behav 51:487-491, 1992
12. Corwin MJ, Lester BM, Sepkoski C, McLaughlin S, Kayne H, Golub HL: Effects of in utero cocaine on newborn acoustical cry characteristics. Pediatrics 89:1199-1203, 1992
13. Chiriboga CA, Brust JC, Bateman DA, Hauser WA: Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 103:79-85, 1999
14. Kilbride HW, Castor C, Shaw W: Obstetrical history and selective screening are not adequate to identify fetal drug exposure (abstract). Clin Res 42:79A, 1994
15. Prechtl H: The Neurological Examination of the Full-Term Newborn Infants, 2nd ed. London, UK, Heinmann Medical for Spastics International Medical Publications, 1977
16. Duncan CC, Ment LR, Smith B, Ehrenkranz RA: A scale of the assessment of neonatal neurologic states. Childs Brain 8:299-306, 1981
17. Amiel-Tison C, Grenier A (adapted by Steichen J, Steichen-Ach P, Braun CB): Neurologic Evaluation of the Newborn and the Infant. New York, NY, Masson Publishing, 1983
18. Hamill PVV, Drizd TA, Johnson CL, et al: National Center for Health Statistics percentiles. Am J Clin Nutr 32:607-629, 1979
19. Folio MR, Fewell RR: Peabody Developmental Motor Scales and Activity Cards. Allen, TX, DLM Teaching Resources, 1983
20. Bayley N: Bayley Scales of Infant Development. New York, NY, The Psychological Corporation, 1969
21. Termen LM, Merrill MA: Stanford Binet, 3rd rev. Boston, MA, Houghton Mifflin, 1973
22. Bzoch KR, League R: Receptive-Expressive Emergent Language Scale (REEL). Austin, TX, Pro-Ed, 1970
23. Hedrick DL, Prather EM, Tobin AR: Sequenced Inventory of Communication Development, revised ed. Seattle, WA, University of Washington Press, 1984
24. Desu MM, Raghavarao D: Sample Size Methodology. New York, NY, Academic Press, 1990
25. Chiriboga CA: Cocaine and the fetus: Methodological issues and neurological correlates, in Konkol RJ, Olsen GD (eds): Prenatal Cocaine Exposure. Boca Raton, FL, CRC Press, 1996, pp 1-21
26. Chasnoff IJ, Griffith DR, Freier C, Murray J: Cocaine/polydrug use in pregnancy: Two-year follow-up. Pediatrica 89:284-289, 1992
27. Hurt H, Brodsky NL, Betancourt L, et al: Cocaine-exposed children: Follow-up through 30 months. J Dev Behav Pediatr 16:29-35, 1995
28. Azuma S, Chasnoff IJ: Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three year data. Pediatrics 92:396-402, 1993
29. Hurt H, Malmud E, Betancourt L, Brodsky NL, Giannetta J: A prospective evaluation of early language development in children with in utero cocaine exposure and in control subjects. J Pediatr 130:310-312, 1997
30. Hurt H, Brodsky NL, Betancourt L, Braitman LE, Belsky J, Giannetta J: Play behavior in toddlers with in utero cocaine exposure: A prospective, masked, controlled study. J Dev Behav Pediatr 17:373-379, 1996
31. Hurt H, Malmud E, Betancourt L, Braitman LE, Brodsky NL, Giannetta J: Children with in utero cocaine exposure do not differ from control subjects on intelligence testing. Arch Pediatr Adolesc Med 151:1237-1241, 1997
32. Bender SL, Word CO, DiClemente RJ, Crittenden MR, Persaud NA, Ponton LE: The developmental implications of prenatal and/or postnatal crack cocaine exposure in preschool children: A preliminary report. J Dev Behav Pediatr 16:418-424, 1995
33. Lester BM, Tronick EZ: The effects of prenatal cocaine exposure and child outcome: Lessons from the past. Infant Ment Health J 15:107-120, 1994
34. Sallee FR, Katikaneni LP, McArthur PD, Ibrahim HM, Nesbitt L, Sethuraman G: Head growth in cocaine-exposed infants: Relationship to neonate hair level. J Dev Behav Pediatr 16:77-81, 1995
35. Dixon SD, Bejar R: Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatr 115:770-778, 1989
36. Cohen HL, Sloves JH, Laungani S, Glass L, DeMarinis P: Neurosonographic findings in full-term infants born to maternal cocaine abusers: Visualization of subependymal and periventricular cysts. J Clin Ultrasound 22:327-333, 1994
37. Behnke M, Davis Eyler F, Conlon M, Wobie K, Stewart Woods N, Cumming W: Incidence and description of structural brain abnormalities in newborns exposed to cocaine. J Pediatr 132:291-294, 1998
38. Hofkosh D, Pringle JL, Wald HP, Switala J, Hinderliter SA, Hamel SC: Early interactions between drug-involved mothers and infants: Within-group differences. Arch Pediatr Adolesc Med 149:665-672, 1995
39. Leventhal JM, Forsyth BWC, Qi K, Johnson L, Schroeder D, Votto N: Maltreatment of children born to women who used cocaine during pregnancy: A population-based study. Pediatrics 100:E7, 1997
40. Black MM, Nair P, Kight C, Wachtel R, Roby P, Schuler M: Parenting and early development among children of drug-abusing women: Effects of home intervention. Pediatrics 94:440-448, 1994